Clinical-scale expansion of a mixed population of bone marrow-derived stem and progenitor cells for potential use in bone tissue regeneration

Stem Cells

Volumn 25, Issue 10, 2007, Pages 2575-2582

  Dennis, James E ^a,c   Esterly, Kelly ^b   Awadallah, Amad ^a   Parrish, Christopher R ^b   Poynter, Gregory M ^b   Goltry, Kristin L ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Aastrom Biosciences Inc   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Bioreactor; Bone marrow; Ex vivo expansion; Osteogenesis

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ENDOGLIN; THY 1 ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE TISSUE; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MESENCHYME CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PHENOTYPE; STEM CELL; TISSUE REGENERATION; TISSUE REPAIR;

ADOLESCENT; ADULT; ANIMALS; BIOREACTORS; BONE AND BONES; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; ERYTHROPOIETIN; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-3; MALE; MEMBRANE PROTEINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, SCID; MIDDLE AGED; OSTEOBLASTS; OSTEOGENESIS; PROSTHESES AND IMPLANTS; RECOMBINANT FUSION PROTEINS; TISSUE ENGINEERING;

EID: 35348826637     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0204     Document Type: Article

References (54)

1. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192-195.
2. Ollier L. Traite experimentale it clinique de ea regeneration des os et de la production artificielle du tissu osseux. In: Masson V, ed. Paris, 1867: 117-118.
3. Goujon E. Recherches experimentales sur les proprietes physiologiques de la moelle des os. Journal de L'Anat et de La Physiol 1869;6:399-412.
4. Baikow A. Uber transplantation von knochenmark. Centalbl F D Med Wiss 1870;8:371-373.
5. Owen M, Friedenstein AJ. Stromal stem cells: Marrow-derived osteogenic precursors. Ciba Foundation Symposium 1988;136:42-60.
6. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9:641-650.
7. Dennis JE, Merriam A, Awadallah A et al. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 1999;14:700-709.
8. Dennis JE, Charbord P. Origin and differentiation of human and murine stroma. STEM CELLS 2002;20:205-214.
9. Dennis JE, Caplan AI. Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of a H-2KbtsA58 transgenic mouse. J Cell Physiol 1996;167:523-538.
10. Friedenstein AJ. Precursor cells of mechanocytes. Int Rev Cytol 1976;47:327-359.
11. Friedenstein AJ. Determined and inducible osteogenic precursor cells. In: Elliott K, Fitzsimons D, eds. Hard Tissue Growth, Repair and Remineralization. Vol 11. North-Holland, Amsterdam: Elsevier-Exerpta Medica, 1973:169-185.
12. Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem cells: In vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 1987;20:263-272.
13. Pittenger M, Mackay A, Beck S et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
14. Jiang Y, Jahagirdar B, Reinhard L et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49.
15. Grundel R, Chapman M, Yee T et al. Autogeneic bone marrow and porous biphasic calcium phosphate ceramic for segmental bone defects in the canine ulna. Clin Orthop 1991;266:244-258.
16. Werntz J, Lane J, Burstein A et al. Qualitative and quantitative analysis of orthotopic bone regeneration by marrow. J Orthop Res 1996;14:85-93.
17. Muschler GF, Hiromori N, Matsukura Y et al. Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clin Orthop Relat Res 2003;407:102-118.
18. Bruder SP, Kraus KH, Goldberg V et al. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 1998;80:985-996.
19. Kadiyala S, Jaiswal N, Bruder SP. Culture-expanded, bone marrow derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect. Tissue Eng 1997;3:173-185.
20. Bruder SP, Kurth AA, Shea M et al. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 1998;16:155-162.
21. Schwartz R, Palsson B, Emerson S. Rapid medium perfusion rate significantly increases the productivity and longevity of human bone marrow cultures. Proc Natl Acad Sci U S A 1991;88:6760-6764.
22. Schwartz R, Emerson S, Clarke M et al. In vitro myelopoiesis stimulated by rapid medium exchange and supplementation with hematopoietic growth factors. Blood 1991;78:3155-3161.
23. Caldwell J, Palsson BO, Locey B et al. Culture perfusion schedules influence the metabolic activity and granulocyte-macrophage colony-stimulating factor production rates of human bone marrow stromal cells. J Cell Physiol 1991;147:344-353.
24. Smith D, Gorgas G, Hastie K et al. Enhanced yield and antigen presenting function of human dendritic cells produced under perfusion culture conditions in a unique clinical-scale bioreactor system. Keystone Symposia: Dendritic Cells: Interfaces with Immunobiology and Medicine; March 12, 2001; Taos, New Mexico.
25. Armstrong R, Smith D, Mandalam R et al. Continuous medium perfusion during ex vivo expansion of human CD8+ T-cells produces high density cultures and enhances proliferation potential and lymphokine release. Exp Hematol 1997;25:886a.
26. Mandalam R, Koller M, Smith A. Ex vivo hematopoietic cell expansion for bone marrow transplantation. In: Schindhelm K, Nordon R, eds. Ex Vivo Cell Therapy. San Diego: Academic Press, 1999:273-291.
27. Pecora A, Stiff P, LeMaistre C et al. A phase II trial evaluating the safety and effectiveness of the AastromReplicell System for augmentation of low-dose blood stem cell transplantation. Bone Marrow Transplant 2001;28:295-303.
28. Stiff P, Chen B, Franklin W et al. Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood 2000;95:2169-2174.
29. Dennis JE, Konstantakos EK, Arm D et al. In vivo osteogenesis assay: A rapid method for quantitative analysis. Biomaterials 1998;19:1323-1328.
30. Mechtersheimer G, Moller P. Expression of aminopeptidase N (CD13) in mesenchymal tumors. Am J Pathol 1990;137:1215-1222.
31. Jones EA, Kinsey SE, English A et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002;46:3349-3360.
32. Deans RJ, Moseley AB. Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol 2000;28:875-884.
33. Devine SM. Mesenchymal stem cells: Will they have a role in the clinic? J Cell Biochem Suppl 2002;38:73-79.
34. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970;3:393-403.
35. Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992;13:69-80.
36. Barry F, Boynton R, Haynesworth S et al. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun 1999;265:134-139.
37. Bruder SB, Horowitz MD, Mosca JD et al. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 1997;21:225-235.
38. Bruder S, Ricalton N, Boynton R et al. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. J Bone Miner Res 1998;13:655-663.
39. + subset colocated with mesenchymal progenitors in human normal bone marrow hematon units is enriched in colony-forming unit megakaryocytes and ling-term culture-initiating cells. Exp Hematol 2003;31:1275-1283.
40. Tiedeman JJ, Connolly JF, Strates BS et al. Treatment of nonunion by percutaneous injection of bone marrow and demineralized bone matrix. An experimental study in dogs. Clin Orthop Relat Res 1991;268:294-302.
41. Connolly JF, Guse R, Tiedeman J et al. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res 1991;266:259-270.
42. Hernigou P, Poignard A, Beaujean F et al. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg 2005;87:1430-1437.
43. Filshie RIA, Zannettino ACW, Makrynilola V et al. MUC18, a member of the immunoglobulin superfamily, is expressed on bone marow fibroblasts and a subset of hematological malignancies. Leukemia 1998;12:414-421.
44. + Marrow cell population is multi-potential. Cells Tissues Organs 2002;170:73-82.
45. + fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994;84:4164-4173.
46. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991;78:55-62.
47. Quarto R, Thomas D, Liang CT. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int 1995;56:123-129.
48. D'Ippolito G, Schiller PC, Ricordi C et al. Age-related decrease in the osteogenic potential of human bone marrow mesenchymal stromal stem cells. Nineteenth Annual Meeting of the American Society for Bone and Mineral Research, Cincinnati, OH, 1997. Blackwell Science, Inc; Vol 12.
49. Gundle R, Beresford JN. The isolation and culture of cells from explants of human trabecular bone. Calcif Tissue Int 1995;56:S8-S10.
50. Phinney D, Kopen G, Righter W et al. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 1999;75:424-436.
51. Walsh S, Jordan GR, Jefferiss C et al. High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of osteoblast precursors in vitro: Relevance to glucocorticoid- induced osteoporosis. Rheumatology 2001;40:74-83.
52. Stewart K, Monk P, Walsh S et al. STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow sroma cells and their more differentiated progeny: A comparative investigation in vitro. Cell Tissue Res 2003;313:281-290.
53. Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1 alpha. J Cell Physiol 1996;166:585-592.
54. Majors A, Boehm CA, Nitto H et al. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res 1997;15:546-557.